UNIGE document Scientific Article
previous document  unige:31166  next document
add to browser collection
Title

Où en est-on dans le traitement des ostéomyélites chronique?

Authors
Published in Revue médicale suisse. 2013, vol. 9, no. 383, p. 885-9
Abstract Chronic osteomyelitis is a multifaceted bacterial infection with common features, which requires surgery for remission. The duration and modality of concomitant administration of antibiotic agents for adult patients is still based on expert opinions. The traditional recommendation of 6 to 12 weeks of antibiotic therapy with intravenous administration for at least the first 2 weeks is more and more challenged in favor of an oral antibiotic treatment with selected agents from the start. There is no evidence that the total duration of antibiotic therapy for more than 6-12 weeks improves outcome, when compared with shorter regimens. External advice from an expert team with combined surgeons and infectious disease physicians may help to reduce antibiotic consumption in a cost-effective way.
Keywords Anti-Bacterial Agents/therapeutic useChronic DiseaseDiabetic Foot/drug therapyHumansOsteomyelitis/diagnosis/microbiology/therapy
Identifiers
PMID: 23697083
Full text
Article (Published version) (555 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Other version: http://rms.medhyg.ch/numero-383-page-885.htm
Structures
Research groups Chirurgie orthopédique et traumatologique (98)
Glycopeptide résistance (28)
Groupe Laurent Kaiser (virologie clinique) (668)
Citation
(ISO format)
CELIK, Hamza et al. Où en est-on dans le traitement des ostéomyélites chronique?. In: Revue médicale suisse, 2013, vol. 9, n° 383, p. 885-9. https://archive-ouverte.unige.ch/unige:31166

264 hits

1 download

Update

Deposited on : 2013-11-20

Export document
Format :
Citation style :